These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 3818608)

  • 1. The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence.
    Kemp BE; Pearson RB; Guerriero V; Bagchi IC; Means AR
    J Biol Chem; 1987 Feb; 262(6):2542-8. PubMed ID: 3818608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit skeletal muscle myosin light chain kinase. The calmodulin binding domain as a potential active site-directed inhibitory domain.
    Kennelly PJ; Edelman AM; Blumenthal DK; Krebs EG
    J Biol Chem; 1987 Sep; 262(25):11958-63. PubMed ID: 3624242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial requirements for location of basic residues in peptide substrates for smooth muscle myosin light chain kinase.
    Kemp BE; Pearson RB
    J Biol Chem; 1985 Mar; 260(6):3355-9. PubMed ID: 3838312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the pseudosubstrate sequence in smooth muscle myosin light chain kinase thermal stability.
    Faux MC; Pearson RB; Mitchelhill KI; Kemp BE
    J Biol Chem; 1993 Jun; 268(17):12484-91. PubMed ID: 8509388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmodulin binding domains: characterization of a phosphorylation and calmodulin binding site from myosin light chain kinase.
    Lukas TJ; Burgess WH; Prendergast FG; Lau W; Watterson DM
    Biochemistry; 1986 Mar; 25(6):1458-64. PubMed ID: 3754463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of a synthetic heptadecapeptide by smooth muscle myosin light chain kinase.
    Kemp BE; Pearson RB; House C
    J Biol Chem; 1982 Nov; 257(22):13349-53. PubMed ID: 6897243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoregulation of enzymes by pseudosubstrate prototopes: myosin light chain kinase.
    Pearson RB; Wettenhall RE; Means AR; Hartshorne DJ; Kemp BE
    Science; 1988 Aug; 241(4868):970-3. PubMed ID: 3406746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the calmodulin-binding and catalytic domains in skeletal muscle myosin light chain kinase.
    Edelman AM; Takio K; Blumenthal DK; Hansen RS; Walsh KA; Titani K; Krebs EG
    J Biol Chem; 1985 Sep; 260(20):11275-85. PubMed ID: 3897230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of a monoclonal antibody directed to the calmodulin-binding domain of rabbit skeletal muscle myosin light chain kinase.
    Nunnally MH; Blumenthal DK; Krebs EG; Stull JT
    Biochemistry; 1987 Sep; 26(18):5885-90. PubMed ID: 2445376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three amino acid substitutions in domain I of calmodulin prevent the activation of chicken smooth muscle myosin light chain kinase.
    VanBerkum MF; Means AR
    J Biol Chem; 1991 Nov; 266(32):21488-95. PubMed ID: 1657969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum requirements for inhibition of smooth-muscle myosin light-chain kinase by synthetic peptides.
    Hunt JT; Floyd DM; Lee VG; Little DK; Moreland S
    Biochem J; 1989 Jan; 257(1):73-8. PubMed ID: 2920029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smooth muscle myosin light chain kinase. Amino acid sequence at the site phosphorylated by adenosine cyclic 3',5'-phosphate-dependent protein kinase whether or not calmodulin is bound.
    Payne ME; Elzinga M; Adelstein RS
    J Biol Chem; 1986 Dec; 261(35):16346-50. PubMed ID: 3782123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
    Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
    Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and tertiary structure of the principal human adenylate kinase.
    Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
    Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent peptide inhibitors of smooth muscle myosin light chain kinase: mapping of the pseudosubstrate and calmodulin binding domains.
    Foster CJ; Johnston SA; Sunday B; Gaeta FC
    Arch Biochem Biophys; 1990 Aug; 280(2):397-404. PubMed ID: 2369131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyamino acid specificity of smooth muscle myosin light chain kinase.
    Pearson RB; Floyd DM; Hunt JT; Lee VG; Kemp BE
    Arch Biochem Biophys; 1988 Jan; 260(1):37-44. PubMed ID: 3341750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary structure required for the inhibition of smooth muscle myosin light chain kinase.
    Ikebe M; Reardon S; Fay FS
    FEBS Lett; 1992 Nov; 312(2-3):245-8. PubMed ID: 1426258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical properties of chimeric skeletal and smooth muscle myosin light chain kinases.
    Leachman SA; Gallagher PJ; Herring BP; McPhaul MJ; Stull JT
    J Biol Chem; 1992 Mar; 267(7):4930-8. PubMed ID: 1371510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrasteric regulation of myosin light chain kinase: the pseudosubstrate prototope binds to the active site.
    Bagchi IC; Kemp BE; Means AR
    Mol Endocrinol; 1992 Apr; 6(4):621-6. PubMed ID: 1584224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of calmodulin and a calmodulin-binding peptide from myosin light chain kinase: major spectral changes in both occur as the result of complex formation.
    Klevit RE; Blumenthal DK; Wemmer DE; Krebs EG
    Biochemistry; 1985 Dec; 24(27):8152-7. PubMed ID: 3841496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.